Michael R. Dougherty Joins The Board Of ViralClear Pharmaceuticals, A Majority-owned Subsidiary Of BioSig Technologies, Inc.

Press/Media: Expert Comment

PeriodMay 28 2020

Media coverage

20

Media coverage

Keywords

  • COVID-19